CGEN
Compugen
NASDAQ: CGEN · HEALTHCARE · BIOTECHNOLOGY
$2.66
+2.31% today
Updated 2026-04-30
Market cap
$268.77M
P/E ratio
7.45
P/S ratio
3.69x
EPS (TTM)
$0.38
Dividend yield
—
52W range
$1 – $3
Volume
0.4M
Compugen (CGEN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
48.60%
Operating margin
83.20%
ROE
44.80%
ROA
14.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $215000.00 | $-13.02M | 97.21% | -6,508.37% | -6,055.81% |
| 2007 | $180000.00 | $-12.11M | 100.00% | -6,922.22% | -6,730.00% |
| 2008 | $338000.00 | $-12.53M | 97.93% | -3,820.12% | -3,706.21% |
| 2009 | $250000.00 | $-3.83M | 100.00% | -3,051.60% | -1,532.40% |
| 2010 | $1.11M | $-7.20M | 79.91% | -706.55% | -646.01% |
| 2011 | $-424000.00 | $-12.00M | 200.00% | 2,825.24% | 2,831.13% |
| 2012 | $242000.00 | $-13.63M | 16.94% | -5,595.87% | -5,631.40% |
| 2013 | $3.55M | $-14.08M | 29.30% | -480.22% | -396.82% |
| 2014 | $12.37M | $-11.09M | 72.96% | -99.76% | -89.71% |
| 2015 | $9.28M | $-20.16M | 82.40% | -225.48% | -217.34% |
| 2016 | $712000.00 | $-31.51M | 68.68% | -4,576.26% | -4,425.00% |
| 2017 | $0.00 | $-37.07M | — | — | — |
| 2018 | $17.80M | $-22.60M | 94.19% | -130.49% | -126.96% |
| 2019 | $0.00 | $-27.34M | — | — | — |
| 2020 | $2.00M | $-27.26M | 97.00% | -1,574.80% | -1,363.00% |
| 2021 | $6.00M | $-32.87M | 88.67% | -584.57% | -547.88% |
| 2022 | $7.50M | $-33.69M | 87.00% | -471.65% | -449.25% |
| 2023 | $33.46M | $-18.75M | 94.01% | -38.83% | -56.05% |
| 2024 | $27.86M | $-14.23M | 71.54% | -53.44% | -51.07% |
| 2025 | $72.76M | $35.34M | 87.29% | 43.05% | 48.57% |